Meno a priezvisko:
|
RNDr. Martina Labudová, PhD.
|
Typ dokumentu:
|
Vedecko/umelecko-pedagogická charakteristika osoby
|
Názov vysokej školy:
|
Univerzita Komenského v Bratislave
|
Sídlo vysokej školy:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
---|---|---|
samostatný vedecký pracovník | Virologický ústav BMC, SAV vvi | 2009-súčastnosť |
odborný asistent | Prírodovedecká fakulta UK | 2022-súčastnosť |
V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
---|---|---|---|
Patogenéza vírusových nákaz a lekárska virológia | Biológia | magisterský | Mikrobiológia a virológia |
V.5.a - Názov predmetu | V.5.b - Študijný program | V.5.c - Stupeň | V.5.d - Študijný odbor |
---|---|---|---|
Onkogénne vírusy | Biológia | magisterské | Mikrobiológia a virológia |
Bunkové kultúry | Biológia | magisterské | Mikrobiológia a virológia |
cvičenia k predmetu Virology | Erasmus Biológia | prvý | Biológia |
Tomaskova J., Labudova M., Kopacek J., Pastorekova S., Pastorek J. (2008). Molecular characterization of the genes coding for glycoprotein and L protein of lymphocytic choriomeningitis virus strain MX. Virus Genes37(1):31-8; DOI: 10.1007/s11262-008-0240-2
Labudova M., Tomaskova J., Skultety L., Pastorek J., Pastorekova S. (2009). The nucleoprotein of lymphocytic choriomeningitis virus facilitates spread of persistent infection through stabilization of the keratin network. J. Virol. 83(16):7842-9; DOI: 10.1128/JVI.00309-09
Gibalová L., Sedlák J., Labudová M., Barančík M., Reháková A., Breier A., Sulová Z. (2009). Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein- mediated drug efflux activity. Gen. Physiol. Biophys. 28(4):391-403; DOI: 10.4149/pb_2009_04_391
Tomaskova J., Oveckova I., Labudova M., Lukacikova L., Laposova K., Kopacek J., Pastorekova S., Pastorek J. (2011). Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus. J. Virol. 85(24):13069-76; DOI: 10.1128/JVI.00829-11
Ditte Z., Ditte P., Labudova M., Simko V., Iuliano F., Zatovicova M., Csaderova L., Pastorekova S., Pastorek J. (2014). Carnosine inhibits carbonic anhydrase IX-mediated extracellular acidosis and suppresses growth of HeLa tumor xenografts. BMC Cancer 22(14):358; DOI: 10.1186/1471-2407-14-358
Supolikova M., Novakova E., Donatova K., Olejnikova P., Labudova M. (2023). Murine herpesvirus-68-related growth factors treatment correlates with decrease of p53 and HIF-1α protein levels. Pathog. Dis.17:81:ftad004; DOI: 10.1093/femspd/ftad004
Labudova M., Zduriencikova M., Fabianova A., Baratova M., Ditte P., Radvak P., Nemcovicova I., Pastorekova S., Pastorek J. (2019). Absence of keratin 1 restricts the course of infection with lymphocytic choriomeningitis virus strain MX. Acta Virol. 63(2):169-185; DOI: 10.4149/av_2019_209
Labudová M., Čiampor F., Pastoreková S., Pastorek J. (2018). Cell-to-cell transmission of lymphocytic choriomeningitis virus MX strain during persistent infection and its influence on cell migration. Acta Virol. 62(4): 424-434; DOI: 10.4149/av_2018_411
Fabianova A., Barathova M., Csaderova L., Simko V., Zatovicova M., Labudova M., Pastorek J. (2018). Hypoxic marker CA IX and adhesion mediator β-catenin are downregulated by lymphocytic choriomeningitis virus persistent infection. Oncotarget 9(16):12879-12893; DOI: 10.18632/oncotarget.24387
Simko V., Iuliano F., Sevcikova A., Labudova M., Barathova M., Radvak P., Pastorekova S., Pastorek J., Csaderova L. (2017). Hypoxia induces cancer-associated cAMP/PKA signalling through HIF-mediated transcriptional control of adenylyl cyclases VI and VII. Sci. Rep.7(1):10121; DOI: 10.1038/s41598-017-09549-8
The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion
Bamia, A; Marcato, V; Boissière, M; Mansuroglu, Z; Tamietti, C; Romani,M; Simon, D; Tian, G; Niedergang, F; Panthier, JJ; Flamand, M; Souès S; Bonnefoy, E; Jan 2021JOURNAL OF VIROLOGY 95 (1)
Bridging the Gap: Virus Long-Distance Spread via Tunneling Nanotubes
Jansens, RJJ; Tishchenko, A and Favoreel, HW; Apr 2020 JOURNAL OF VIROLOGY 94 (8)
Biocompatible carbon quantum dots for intelligent sensing in food safety applications: Opportunities and sustainability
Khan, A; Ezati, P; Kim JT; Rhim, JW
Mar 2023 MATERIALS TODAY SUSTAINABILITY 21
Biofilm inhibition by biocompatible poly(ε-caprolactone) nanocapsules loaded with essential oils and their cyto/genotoxicity to human keratinocyte cell line
Kapustová, M; Puskárová, A; Bucková, M; Granta, G; Napoli, E; Annusova, A; Mesarosova, M; Kozics, K; Pangallo, D; Geraci, C
Sep 5 2021 INTERNATIONAL JOURNAL OF PHARMACEUTICS 606
Boosting extracellular vesicle secretion
Debbi, L; Guo, SW; Safina, D; Levenberg, S
Oct 2022 BIOTECHNOLOGY ADVANCES 59
CEMEA Centrum pre využitie pokročilých materiálov SAV, ITMS: 313021T081, spoluriešiteľ
APVV-14-0120, Grafénová nanoplatforma na detekciu rakoviny. (2016-2019), riešiteľ
SAS-TUBITAk JRP 2013/02, SAS-TÜBITAK joint research cooperation, BioKer - Vývoj kompozitných keramických materiálov pre bioaplikácie. 2013-2016, riešiteľ
Leona Lauder and George Schwab Foundation, Úloha ektodomény CAIX v nádorovom raste a matastázovaní. (11/2014-12/2015), s preĺžením (12/2015-12/2016), riešiteľ
APVV 22-0565, Alginate-based microcapsules with enhanced stability and biocompatibility for encapsulation of pancreatic islets in diabetes treatment. (2022-2026), spoluriešiteľ